Effects of Long-term Growth Hormone Replacement in Adults With Growth Hormone Deficiency Following Cure of Acromegaly: A KIMS Analysis
The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
Context: GH deficiency (GHD) may occur in adults with cured acromegaly (acroGHD). Objective: Our objective was to examine the effectiveness and safety of GH replacement in acroGHD. Design: This study was a retrospective analysis of data from KIMS (Pfizer International Metabolic Database). Setting: Data were extracted from a pharmaco-epidemiological survey of >16 000 GHD adults from 31 countries. Patients: The effectiveness population included 115 adults with acroGHD and 142 age-, gender-, and body mass index-matched GHD adults with nonfunctioning pituitary adenoma (NFPA) followed up to 5 years on GH. The safety population included 164 adults with acroGHD and 2469 with NFPA, all GH-replaced. Both acroGHD and NFPA were compared with several cohorts from the general population (including the World Health Organization Global Burden of Disease). Outcome Measures: Outcome measures included quality of life (QoL-AGHDA), lipids, serious adverse events, and additional safety endpoints. Results: Median GH dose was 0.3 mg/d in acroGHD and NFPA at 5 years. There were comparable improvements in QoL-AGHDA and total and low-density lipoprotein cholesterol in acroGHD and NFPA. High-density lipoprotein cholesterol increased only in acroGHD. Cardiovascular mortality was increased in acroGHD vs NFPA (standardized mortality ratio = 3.03, P = .02). All-cause mortality was similar in acroGHD (ratio between observed/expected cases [95% confidence interval] = 1.32 [0.70–2.25]) and lower in NFPA [observed/expected = 0.58 [0.48–0.70]) in comparison with the general population. There was no difference in incidence of all cancers, benign or malignant brain tumors, or diabetes mellitus between acroGHD and NFPA. Conclusions: GH replacement has comparable effects on quality of life and lipids in acroGHD and NFPA. Further investigation is needed to examine whether the increased cardiovascular mortality may be attributed to the history of previous GH excess in acroGHD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A prospective study of 42 subjects reported that GH replacement enhanced QOL and improved both body composition and lipid profiles (232).”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [232]
Citations
Cites
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Cancer Incidence in Five Continents
(1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,501
Cancer Incidence in Five Continents
(1966) · doi:10.1007/978-3-642-85849-9 · Cited by 5,936
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s062 · Cited by 5,491
Statistical Methods in Cancer Research. Volume II – The Design and Analysis of Cohort Studies
Juul, S. (1989) · Scandinavian Journal of Social Medicine · doi:10.1177/140349488901700214 · Cited by 3,592
The design and analysis of cohort studies
Breslow, N. E., & Day, N. E. (1987) · International Agency for Research on Cancer eBooks · Cited by 1,312
Molitch, M. E., Clemmons, D. R., Malozowski, S., Merriam, G. R., & Vance, M. L. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0179 · Cited by 1,047
Statistical methods in cancer research
Gardner, B. (2001) · Journal of Surgical Oncology · doi:10.1002/jso.1170 · Cited by 777
Ho, K. K. Y., & _, _. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0631 · Cited by 615
Mortality in Patients with Pituitary Disease
Sherlock, M., Ayuk, J., Tomlinson, J. W., Toogood, A. A., Aragon-Alonso, A., Sheppard, M. C., Bates, A. S., & Stewart, P. M. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0033 · Cited by 392
Growth hormone, the insulin-like growth factor axis, insulin and cancer risk
Clayton, P. E., Banerjee, I., Murray, P. G., & Renehan, A. G. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.171 · Cited by 364
Maison, P., Griffin, S., Nicoue-Beglah, M., Haddad, N., Balkau, B., & Chanson, P. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030840 · Cited by 362
Brabant, G., von zur Mühlen, A., Wüster, C., Ranke, M. B., Kratzsch, J., Kiess, W., Ketelslegers, J.-M., Wilhelmsen, L., Hulthén, L., Saller, B., et al. (2003) · Hormone Research in Paediatrics · doi:10.1159/000071871 · Cited by 360
Self-citationMeisinger, C., Thorand, B., Schneider, A., Stieber, J., Döring, A., & Löwel, H. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.1.82 · Cited by 304
Ionizing radiation and the risk of brain and central nervous system tumors: a systematic review
Braganza, M. Z., Kitahara, C. M., Berrington de Gonzalez, A., Inskip, P. D., Johnson, K. J., & Rajaraman, P. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos208 · Cited by 303
Burman, P. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.12.3585 · Cited by 290
Weaver, J. U. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.1.153 · Cited by 282
Population-Based Incidence Rates and Risk Factors for Type 2 Diabetes in White Individuals
Bonora, E., Kiechl, S., Willeit, J., Oberhollenzer, F., Egger, G., Meigs, J. B., Bonadonna, R. C., & Muggeo, M. (2004) · Diabetes · doi:10.2337/diabetes.53.7.1782 · Cited by 270
McKenna, S. P., Doward, L. C., Alonso, J., Kohlmann, T., Niero, M., Prieto, L., & Wíren, L. (1999) · Quality of Life Research · doi:10.1023/a:1008987922774 · Cited by 263
Changes in incidence of diabetes in U.S. adults, 1997–2003
Geiss, L. S., Pan, L., Cadwell, B., Gregg, E. W., Benjamin, S. M., & Engelgau, M. M. (2006) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2005.12.009 · Cited by 229
Incidence of type 1 and type 2 diabetes in adults and children in Kronoberg, Sweden
Thunander, M., Petersson, C., Jonzon, K., Fornander, J., Ossiansson, B., Torn, C., Edvardsson, S., & Landin-Olsson, M. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.07.022 · Cited by 218
Rathmann, W., Strassburger, K., Heier, M., Holle, R., Thorand, B., Giani, G., & Meisinger, C. (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02863.x · Cited by 181
Long-Term Follow-Up Results of Postoperative Radiotherapy in 36 Patients with Acromegaly
Biermasz, N. R., Dulken, H. V., & Roelfsema, F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.7.2476 · Cited by 179
Baum, H. B. A., Katznelson, L., Sherman, J. C., Biller, B. M. K., Hayden, D. L., Schoenfeld, D. A., Cannistraro, K. E., & Klibanski, A. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.9.5112 · Cited by 174
Self-citationSalvati, M., Frati, A., Russo, N., Caroli, E., Polli, F. M., Minniti, G. C., & Delfini, R. (2003) · Surgical Neurology · doi:10.1016/s0090-3019(03)00137-x · Cited by 168
Annamalai, A. K., Webb, A., Kandasamy, N., Elkhawad, M., Moir, S., Khan, F. Z., Maki-Petaja, K. M., Gayton, E. L., Strey, C. H., O’Toole, S. M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3072 · Cited by 138
Quality of Life of Adults with Growth Hormone Deficiency: a Controlled Study
BJORK, S., JONSSON, B., WESTPHAL, O., & LEVIN, J. ‐. (1989) · Acta Paediatrica · doi:10.1111/j.1651-2227.1989.tb11242.x · Cited by 135
Overall and cause-specific mortality in GH-deficient adults on GH replacement
Gaillard, R. C., Mattsson, A. F., Åkerblad, A.-C., Bengtsson, B.-Å., Cara, J., Feldt-Rasmussen, U., Kołtowska-Häggström, M., Monson, J. P., Saller, B., Wilton, P., et al. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-1028 · Cited by 130
Self-citationStatistical methods in cancer research
Gardner, B. (2001) · Journal of Surgical Oncology · doi:10.1002/jso.1170.abs · Cited by 122
Koltowska-Häggström, M., Mattsson, A. F., Monson, J. P., Kind, P., Badia, X., Casanueva, F. F., Busschbach, J., Koppeschaar, H. P. F., & Johannsson, G. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02176 · Cited by 93
Self-citationFeldt-Rasmussen, U., Abs, R., Bengtsson, B., Bennmarker, H., Bramnert, M., Hernberg-Stahl, E., Monson, J., Westberg, B., Wilton, P., & Wuster, C. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1460067 · Cited by 84
Self-citationLong-Term Safety of Growth Hormone Replacement after CNS Irradiation
Mackenzie, S., Craven, T., Gattamaneni, H. R., Swindell, R., Shalet, S. M., & Brabant, G. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0112 · Cited by 83
Baum, H. B. A. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.9.3184 · Cited by 80
Luger, A., Mattsson, A. F., KoŁtowska-Häggström, M., Thunander, M., Góth, M., Verhelst, J., & Abs, R. (2012) · Diabetes Care · doi:10.2337/dc11-0449 · Cited by 79
Self-citationThirty Years of Bioethics: The Helsinki Declaration 1964-2003
Riis, P. (2003) · New Review of Bioethics · doi:10.1080/1740028032000131396 · Cited by 78
Attanasio, A. F., Jung, H., Mo, D., Chanson, P., Bouillon, R., Ho, K. K. Y., Lamberts, S. W. J., Clemmons, D. R., & for the HypoCCS International Advisory Board (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0448 · Cited by 74
Prasad, G., & Haas-Kogan, D. A. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.98 · Cited by 74
Espinosa-de-los-Monteros, A. L., González‐Virla, B., Vargas‐Ortega, G., Sosa, E., & Mercado, M. (2010) · Pituitary · doi:10.1007/s11102-010-0284-x · Cited by 71
Wexler, T., Gunnell, L., Omer, Z., Kuhlthau, K., Beauregard, C., Graham, G., Utz, A. L., Biller, B., Nachtigall, L., Loeffler, J., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2671 · Cited by 69
Self-citationMiller, K. K., Wexler, T., Fazeli, P., Gunnell, L., Graham, G. J., Beauregard, C., Hemphill, L., Nachtigall, L., Loeffler, J., Swearingen, B., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1611 · Cited by 66
Self-citationExcess mortality in women with pituitary disease: a meta‐analysis
Nielsen, E. H., Lindholm, J., & Laurberg, P. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02947.x · Cited by 58
Attanasio, A. F., Shavrikova, E. P., Blum, W. F., & Shalet, S. M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0439 · Cited by 56
Jayasena, C. N., Comninos, A. N., Clarke, H., Donaldson, M., Meeran, K. M., & Dhillo, W. S. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04019.x · Cited by 54
Kołtowska-Häggström, M., Hennessy, S., Mattsson, A. F., Monson, J. P., & Kind, P. (2005) · Hormone Research in Paediatrics · doi:10.1159/000087444 · Cited by 49
Self-citationAbs, R., Mattsson, A. F., Thunander, M., Verhelst, J., Góth, M. I., Wilton, P., Kołtowska-Häggström, M., & Luger, A. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-0807 · Cited by 49
Self-citationMonson, J. P., Jönsson, P., Koltowska‐Häggström, M., & Kourides, I. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02935.x · Cited by 42
van der Klaauw, A. A., Bax, J. J., Roelfsema, F., Stokkel, M. P. M., Bleeker, G. B., Biermasz, N. R., Smit, J. W. A., Romijn, J. A., & Pereira, A. M. (2009) · Pituitary · doi:10.1007/s11102-009-0186-y · Cited by 41
Tritos, N. A., Greenspan, S. L., King, D., Hamrahian, A., Cook, D. M., Jönsson, P. J., Wajnrajch, M. P., Koltowska-Häggstrom, M., & Biller, B. M. K. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2662 · Cited by 40
Self-citationLin, E., Wexler, T. L., Nachtigall, L., Tritos, N., Swearingen, B., Hemphill, L., Loeffler, J., Biller, B. M. K., Klibanski, A., & Miller, K. K. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04361.x · Cited by 37
Self-citationNorrman, L.-L., Johannsson, G., Sunnerhagen, K. S., & Svensson, J. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2673 · Cited by 37
Self-citationPrevalence of GH deficiency in cured acromegalic patients: impact of different previous treatments
Ronchi, C. L., Giavoli, C., Ferrante, E., Verrua, E., Bergamaschi, S., Ferrari, D. I., Corbetta, S., Montefusco, L., Arosio, M., Ambrosi, B., et al. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0222 · Cited by 34
The diagnosis of growth hormone deficiency (GHD) in successfully treated acromegalic patients
Murray, R. D., Peacey, S. R., Rahim, A., Toogood, A. A., Thorner, M. O., & Shalet, S. M. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01189.x · Cited by 29
Update in Mortality in GH-Treated Patients
Erfurth, E. M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2415 · Cited by 29
Giavoli, C., Profka, E., Verrua, E., Ronchi, C. L., Ferrante, E., Bergamaschi, S., Sala, E., Malchiodi, E., Lania, A. G., Arosio, M., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2477 · Cited by 25
The diagnosis and treatment of growth hormone deficiency in adults
Clemmons, D. R. (2010) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32833b6bc7 · Cited by 22
Abrams, P. J., Boquete, H., Fideleff, H. L., Feldt‐Rasmussen, U., Jönsson, P., Kołtowska‐Häggström, M., Wilton, P., & Abs, R. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0448 · Cited by 21
Self-citationValassi, E., Brick, D. J., Johnson, J. C., Biller, B. M. K., Klibanski, A., & Miller, K. K. (2012) · Endocrine Practice · doi:10.4158/ep11134.or · Cited by 19
Self-citationTritos, N. A., Hamrahian, A. H., King, D., Greenspan, S. L., Cook, D. M., Jönsson, P. J., Koltowska‐Häggstrom, M., & Biller, B. M. K. (2013) · Clinical Endocrinology · doi:10.1111/cen.12132 · Cited by 18
Self-citationSevere growth hormone deficiency is rare in surgically-cured acromegalics
Fujio, S., Tokimura, H., Hirano, H., Hanaya, R., Kubo, F., Yunoue, S., Bohara, M., Kinoshita, Y., Tominaga, A., Arimura, H., et al. (2012) · Pituitary · doi:10.1007/s11102-012-0424-6 · Cited by 13
van der Klaauw, A. A., Bax, J. J., Bleeker, G. B., Holman, E. R., Delgado, V., Smit, J. W. A., Romijn, J. A., & Pereira, A. M. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0496 · Cited by 10
Research works printed but not linked: 1
- Mathers, 2003, Global burden of disease in 2002: data sources, methods and results, 1
Cited by
Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline
Fleseriu, M., Hashim, I. A., Karavitaki, N., Melmed, S., Murad, M. H., Salvatori, R., & Samuels, M. H. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2118 · Cited by 945
Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An Update
Gadelha, M. R., Kasuki, L., Lim, D. S. T., & Fleseriu, M. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00115 · Cited by 363
Acromegaly at diagnosis in 3173 patients from the Liège Acromegaly Survey (LAS) Database
Petrossians, P., Daly, A. F., Natchev, E., Maione, L., Blijdorp, K., Sahnoun-Fathallah, M., Auriemma, R., Diallo, A. M., Hulting, A.-L., Ferone, D., et al. (2017) · Endocrine-Related Cancer · doi:10.1530/erc-17-0253 · Cited by 263
Long‐term safety of growth hormone—A combined registry analysis
Stochholm, K., & Kiess, W. (2018) · Clinical Endocrinology · doi:10.1111/cen.13502 · Cited by 74
Impact of adult growth hormone deficiency on metabolic profile and cardiovascular risk [Review]
Giovannini, L., Tirabassi, G., Muscogiuri, G., Somma, C. D., Colao, A., & Balercia, G. (2015) · Endocrine Journal · doi:10.1507/endocrj.ej15-0337 · Cited by 64
Metadata
- Authors
- Tritos, N. A., Johannsson, G., Korbonits, M., Miller, K. K., Feldt-Rasmussen, U., Yuen, K. C. J., King, D., Mattsson, A. F., Jonsson, P. J., Koltowska-Haggstrom, M., Klibanski, A., & Biller, B. M. K.
- Affiliations
- Harvard University (US)
- Department of Endocrinology (G.J.), Gothenburg, Sweden SE-41345;
- Queen Mary University of London (GB)
- Department of Medical Endocrinology (U.F.-R.), Rigshospitalet, National University Hospital, Copenhagen University, Copenhagen, Denmark DK-2100;
- Oregon Health & Science University (US)
- Pfizer (United States) (US)
- Sahlgrenska University Hospital (SE)
- Pfizer Endocrine Care (P.J.J., M.K.-H.), Sollentuna, Sweden SE-19091
- Corresponding author
- Tritos, Nicholas A.
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2014-06-01
- Volume
- 99
- Issue
- 6
- Pages
- 2018-2029
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2110254569
- Semantic Scholar
- 0edb100ad91356528e24d024cbe0b2264dbb00eb
- Cited by
- 31
- References
- 59
- Citations by year
- 2023: 3 · 2022: 7 · 2021: 1 · 2020: 3 · 2018: 1 · 2017: 5 · 2016: 3 · 2015: 6 · 2014: 2
- FWCI
- 4.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- Pfizer
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- growth hormone replacement therapy, acromegaly, non-functioning pituitary adenoma, quality of life, lipids, cardiovascular mortality, all-cause mortality, serious adverse events, cancer incidence, diabetes mellitus, brain tumors
- MeSH terms
- Acromegaly, Adult, Aged, Female, Follow-Up Studies, Humans, Hypopituitarism, Male, Middle Aged, Remission Induction, Retrospective Studies, Databases, Factual, Treatment Outcome, Human Growth Hormone, Hormone Replacement Therapy, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.